Skip to content

GS PHARMA

Active Private limited companyfounded 2012active for 14 yearsBrusselstraat 5, 1702 DilbeekKBO/BCE: BE 0848.422.277 subsidiary of

Timeline

20 events since 2012

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBabbreviated format · 41 days before the deadline
2025
Highest result from 2013 to 2025 net €124,005 ▲693% The operating result of €135,015 and the net result of €124,005 are both a record.
Annual accounts 2024 filed PDFabbreviated format · 77 days late
2024
Annual accounts 2023 filed PDFabbreviated format · 28 days late
2023
Annual accounts 2022 filed PDFabbreviated format · 5 days before the deadline
acts as permanent representative holds all the shares · General meeting of 28-04-20235 points ▸
  • Registered office clause, Brusselstraat 5, 1702 Dilbeek
  • Permanent representative,
  • General meeting, 28-04-2023
  • 1,000 shares
  • holds all the shares
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

2022
Back to profit net €2,333 The net result is €2,333, after 3 loss-making years.
Annual accounts 2021 filed PDFabbreviated format · 30 days late
2021
Weakest financial year net -€21,116 The net result drops to -€21,116, the lowest from 2013 to 2025. It recovers the following year.
Annual accounts 2020 filed PDFabbreviated format · 19 days late
2020
Annual accounts 2019 filed PDFabbreviated format · 63 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 19 days late
2018
Annual accounts 2017 filed PDFabbreviated format · 19 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 17 days late
2016
Equity above €150,000 equity €159,647 ▲67.1% With a profit in every financial year since 2013, equity grows to €159,647.
Annual accounts 2015 filed PDFabbreviated format · 24 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 13 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 11 days late
2012
IncorporationFounding capital of €20,000, 1,000 shares · Founded by and · appointed as manager · published on 06-09-20126 points ▸
  • Founder,
  • Founder,
  • Founding capital, €20,000, 1,000 shares
  • Board rule, 1
  • Director appointment, (manager)
  • Permanent representative,
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

First establishment Brusselstraat 5, Dilbeek

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 4 September 2012, GS PHARMA was incorporated by and one private individual, with a starting capital of €20,000.12 is manager of the company, appointed by deed of 06-09-2012.2 Total assets went from €864,371 in 2018 to €796,930 in 2025 and headcount from 1.3 to 2 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-09-2012
  3. 3National Bank, annual accounts 2018 and 2025

Next steps